维普中文期刊产品整合服务
195篇 您的检索式:作者名="Relling Mv"
    题名 作者 年代 出处 被引量
1Moving towards individualized medicine with pharmacogenomics 显示文摘Evans WE Relling MV 2004Nature2004,429,:1
2Racial and gender differences in N-acetyhransferase, xanthine oxidase, and CYP1 A2 activities 显示文摘Relling MV Lin JS Ayem GD 1992Clin Pharmacol Ther1992,52,6:1
3Simultaneous characterization of glu- tathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks显示文摘Chen CL Liu Q Relling MV 1996Pharmacogenet- ics1996,6,2:1
4Clinical pharmacokinetics - pharmacodynamics of anficancer drug显示文摘Evans We Relling Mv 1989Clin Pharmocokinet1989,16,:1
5Acute lymphoblasticleukemia 显示文摘Pui CH Relling MV Downing JR 2004N Engl J Med2004,350,15:1
6Concordence of CYP2D6(debrisonquine hydrolation)phenytype and genoyype:Inability of dextromethorphan metabolic ratio to discriminate reliably heterozygous and homozygous extenssive metabolizers显示文摘Evans WE Relling MV 1991Pharmacogenetics1991,1,:1
7Rationale and design of Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemia显示文摘Pui CH Relling MV Sanglund JT 2004Ann Hematol2004,83,:1
8Acute lymphoblastic leukaemia显示文摘Puic H Relling MV Downing JR 2006N Engl J Med2006,350,11:1
9Blast cell Metho- trexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and Methotrexate dose in acute lymphoblastic leukemia 显示文摘Synold TW Relling MV Boyett JM 1994JClinInvest1994,94,5:1
10Pharmacogenomics: translating functional genomics into rational thera- peutics 显示文摘Evans WE Relling MV 1999Science1999,288,5439:1
11Genetic basis for a lower prevalence of defient CYP2D6 oxidative drug metabolism phenotypes in black American显示文摘Evans WE Relling MV Rahman A 1993Clin Pharmacol1993,91,:1
12Dose pharmacokinetic variability influence the efficacy of high-dose methotrexate for the treatment of childrren with acute lymphoblastic leukemia:what can we learn from small studies显示文摘Evans WE Relling MV Boyett JM 1997Leuk res1997,21,:1
13Acute lymphoblastic leukemia显示文摘Hoelzer D Gkbuget N Ottmann O Pui CH Relling MV Appelbaum FR 2002Hematology Am Soc Hematol Educ Program2002,,:1
14Acute lymphoblastie leukemia 显示文摘Pui CH Relling MV Downing JR 2004NEnglJMed2004,350,15:1
15Acute lymphoblastic leukemia 显示文摘Pui CH Relling MV Downing JR 2004New England Journal of Medicine2004,350,:1
16Acute lymphyoblastic leukemia显示文摘Pui CH Relling MV Downing JR 2004N Engl J Med2004,350,:1
17Dosepharmacokinetic variability influence the efficacy of high-dosemethotrexate for the treatment of children with acutelymphoblastic leukemia : what can we learn from small studies 显示文摘Evans WE Relling MV Boyett JM 1997Leuk Res1997,21,5:1
18Pharmacogenomics: translating functional genomics into rational therapeutics显示文摘Evans WE Relling MV 1999Science1999,286,5439:1
19Pharmagenomies: transla- ting functional genomics into rational therapeutics 显示文摘Evans WE Relling MV 1999Science1999,286,5439:1
20Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing 显示文摘Relling MV Gardner EE Sandborn WJ 2011Clin Pharmacol Ther2011,89,3:1
返回顶部 每页显示:
共10页 首页 上一页 第1页 下一页 末页 /10 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费